CTD-T AM 12.5/40/5 Tablet
By CTD-T AM
Rx
10 Tablet in a Strip

Composition
Telmisartan(40mg) + Amlodipine(5mg) + Chlorthalidone(12.5mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
August, 2026

liver
When using CTD-T AM 12.5/40/5 Tablet, caution is advised in individuals with liver disease. It may be necessary to adjust the dosage of the medication in such cases. Consulting your doctor before taking CTD-T AM 12.5/40/5 Tablet is important, especially if you have any liver conditions. It is advised not to use this medication in patients with severe liver disease.

kidney
CTD-T AM 12.5/40/5 Tablet should be used carefully in patients with severe kidney disease. Adjusting the dose may be necessary, so it's important to consult with your doctor. Avoid using this medication in such patients.

alcohol
When taking CTD-T AM 12.5/40/5 Tablet, avoid consuming alcohol as it is considered unsafe to do so.

driving
CTD-T AM 12.5/40/5 Tablet might lead to side effects like dizziness, headaches, nausea, or tiredness, impacting driving ability due to reduced focus and reaction time.

pregnancy
CTD-T AM 12.5/40/5 Tablet is not safe to use during pregnancy due to potential risk to the developing baby. Use only if doctor prescribes in life-threatening situations with careful consideration of benefits versus risks. It is important to consult your doctor before use.

breastfeeding
CTD-T AM 12.5/40/5 Tablet is considered safe during breastfeeding based on limited data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹137.65
₹152.95
10% OFF
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024